Article
Thrombopoietin knock-in augments platelet generation from human embryonic stem cells
17 Jul 2018
Abstract excerpt
Refinement of therapeutic-scale platelet production in vitro will provide a new source for transfusion in patients undergoing chemotherapy or radiotherapy. However, procedures for cost-effective and scalable platelet generation remain to be established. In this study, we established human embryonic stem cell (hESC) lines containing knock-in of thrombopoietin (TPO) via CRISPR/Cas9-mediated genome editing. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
